American Journal of Neuroradiology, Vol 19, Issue 7 1189-1196, Copyright © 1998 by American Society of Neuroradiology
ARTICLES |
Clinical utility of positron emission tomography with 18F- fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck
NJ Fischbein, OS AAssar, GR Caputo, MJ Kaplan, MI Singer, DC Price, WP Dillon and RA Hawkins
Department of Radiology, University of California, San Francisco 94143, USA.
PURPOSE: The use of positron emission tomography with 18F- fluorodeoxyglucose (FDG-PET) to detect residual/recurrent squamous cell carcinoma of the head and neck has been tested only in small groups of patients. Our purpose, therefore, was to evaluate the ability of this technique to detect the presence of tumor at both primary and nodal sites in a large cohort of patients. METHODS: All patients referred for PET scanning over a 2.5-year period with a question of residual or recurrent squamous cell carcinoma of the head and neck were identified. Thirty-five of 44 patients had sufficient follow-up to be meaningful to our analysis (range, 6-33 months). PET scans were interpreted visually with knowledge of the clinical history and correlative anatomic imaging findings. Detection of disease involving primary and nodal sites was assessed independently. Additionally, because each patient had been referred in an attempt to resolve a specific clinical problem, the usefulness of PET in accurately addressing these questions was assessed. RESULTS: At the primary site, sensitivity and specificity for residual/recurrent disease were 100% and 64%, respectively; for nodal disease, sensitivity and specificity were 93% and 77%, respectively. In helping to resolve the clinical question being asked, the positive predictive value of the test result was 65% and the negative predictive value was 91%. CONCLUSION: The high sensitivity and negative predictive value of PET scanning in our cohort of patients suggest an important role for this technique in the care of patients with suspected residual/recurrent head and neck carcinoma. The lower figures obtained for specificity and positive predictive value reflect the fact that increased FDG uptake may be due to either tumor or inflammation.
This article has been cited by other articles:
 |
|
 |
|
  Y ARIJI, N FUWA, T KODAIRA, H TACHIBANA, T NAKAMURA, Y SATOH, and E ARIJI False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue Br. J. Radiol., January 1, 2009; 82(973): e3 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Abgral, S. Querellou, G. Potard, P.-Y. Le Roux, A. Le Duc-Pennec, R. Marianovski, O. Pradier, Y. Bizais, F. Kraeber-Bodere, and P. Y. Salaun Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up? J. Nucl. Med., January 1, 2009; 50(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marur and A. A. Forastiere Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment Mayo Clin. Proc., April 1, 2008; 83(4): 489 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Kim, S.-w. Lee, S. Y. Nam, K. C. Im, J.-S. Kim, S. J. Oh, S. D. Ahn, S. S. Shin, E. K. Choi, and J. H. Kim The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck J. Nucl. Med., March 1, 2007; 48(3): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quon, N. J. Fischbein, I. R. McDougall, Q.-T. Le, B. W. Loo Jr., H. Pinto, and M. J. Kaplan Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma J. Nucl. Med., January 1, 2007; 48(1_suppl): 58S - 67S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.J. Kim, B.J. Lee, S.J. Kim, W.-Y. Shim, S.K. Baik, and M. Sunwoo Tongue Abscess Mimicking Neoplasia AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2202 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-F. Yen, R.-L. Hong, K.-Y. Tzen, M.-H. Pan, and T. H.-H. Chen Whole-Body 18F-FDG PET in Recurrent or Metastatic Nasopharyngeal Carcinoma J. Nucl. Med., May 1, 2005; 46(5): 770 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Kapoor, M. B. Fukui, and B. M. McCook Role of 18FFDG PET/CT in the Treatment of Head and Neck Cancers: Posttherapy Evaluation and Pitfalls Am. J. Roentgenol., February 1, 2005; 184(2): 589 - 597. [Full Text] [PDF]
|
|
|
|
|
|
N. Shu-Hang, J. C. Tung-Chieh, C. Sheng-Chieh, K. Sheung-Fat, W. Hung-Ming, L. Chun-Ta, C. Yu-Chen, W.-J. Lin, F. Ying-Kai, and Y. Tzu-Chen Clinical Usefulness of 18F-FDG PET in Nasopharyngeal Carcinoma Patients with Questionable MRI Findings for Recurrence J. Nucl. Med., October 1, 2004; 45(10): 1669 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mukherji, I. M. Schmalfuss, J. Castelijns, and A. A. Mancuso Clinical Applications of Tumor Volume Measurements for Predicting Outcome in Patients with Squamous Cell Carcinoma of the Upper Aerodigestive Tract AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1425 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S-H Liu, J T Chang, S-H Ng, S-C Chan, and T-C Yen False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient Br. J. Radiol., March 1, 2004; 77(915): 257 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Goerres, D. T. Schmid, F. Bandhauer, P. U. Huguenin, G. K. von Schulthess, S. Schmid, and S. J. Stoeckli Positron Emission Tomography in the Early Follow-up of Advanced Head and Neck Cancer Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 105 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Goerres and S. J. Stoeckli Imaging Literature and Terminology: When Is It Residual Cancer and When Recurrence? Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 120 - 121. [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mukherji and G. T. Wolf Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment AJNR Am. J. Neuroradiol., October 1, 2003; 24(9): 1743 - 1746. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith Clinical Role of FDG PET in Evaluation of Cancer Patients RadioGraphics, March 1, 2003; 23(2): 315 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mukherji, M. Gapany, D. Phillips, B. Neelon, S. O' O'Brien, W. McCartney, S. Buejenovich, J. S. Parekh, J. P. Noordzij, and M. Castillo Thallium-201 Single-Photon Emission CT versus CT for the Detection of Recurrent Squamous Cell Carcinoma of the Head and Neck AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1215 - 1220. [Abstract] [Full Text]
|
|
|
|
|
|
O. S. AAssar, N. J. Fischbein, G. R. Caputo, M. J. Kaplan, D. C. Price, M. I. Singer, W. P. Dillon, and R. A. Hawkins Metastatic Head and Neck Cancer: Role and Usefulness of FDG PET in Locating Occult Primary Tumors Radiology, January 1, 1999; 210(1): 177 - 181. [Abstract] [Full Text]
|
|